Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 6/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EDNRA | P25101 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HBB | P68871 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 4/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.38 |
| ▸ | MGMT | P16455 | 2/20 | 0.37 |
| ▸ | CDK1 | P06493 | 2/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2346363 | 0.89 | PDE4A (0.44) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL10421281 | 0.88 | CDK1 (0.49) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL1767750 | 0.84 | ADORA2A (0.47) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8397617 | 0.83 | HPRT1 (0.47) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL28721443 | 0.83 | CDK1 (0.53) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL27842808 | 0.82 | PDE4A (0.53) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL28071828 | 0.82 | PNP (0.45) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2343362 | 0.81 | ADORA2A (0.44) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL15013384 | 0.81 | MEN1 (0.40) | PNPBLMPDE4APDE4BPDE4C | |
| SCHEMBL3512359 | 0.81 | PDE4A (0.37) | PNPPDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0531452-A4 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | — | 1993-06-09 | — | — | EP | claimed |
| EP-0531452-A1 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | NeXstar Pharmaceuticals, Inc. (US) | 1993-03-17 | — | — | EP | claimed |
| WO-1991018914-A1 | SYNTHESIS OF GLYCEROL DI- AND TRIPHOSPHATE DERIVATIVES | VICAL, INC. (US) | 1991-12-12 | — | — | WO | claimed |
| CN-108135973-A | Human APOB100 epitopes, methods and uses for modulating inflammatory responses and treating adverse cardiovascular events, diseases and atherosclerosis | 拉·约拉过敏反应及免疫医学研究所 | 2018-06-08 | — | — | CN | disclosed |
| EP-1229939-A1 | USE OF HISTAMINE AS A DRUG DELIVERY ENHANCING COMPOUND FOR USE IN TRANSMUCOSAL OR TRANSDERMAL DELIVERY | Maxim Pharmaceuticals, Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-1143969-A1 | METHODS AND COMPOSITIONS FOR TOPICAL TREATMENT OF DAMAGED TISSUE USING REACTIVE OXYGEN METABOLITE PRODUCTION OR RELEASE INHIBITORS | Maxim Pharmaceuticals, Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6262254-B1 | 8-FLUORO-9-((2-HYDROXYETHOXY)METHYL))GUANINE / (8-FLUOROACYCLOVIR) USEFUL AS ANTICANCER AND ANTIVIRAL AGENT | THE REGENTS OF UNIV. OF CALIFORNIA | 2001-07-17 | — | — | US | disclosed |
| WO-2001008706-A1 | USE OF HISTAMINE AS A DRUG DELIVERY ENHANCING COMPOUND FOR USE IN TRANSMUCOSAL OR TRANSDERMAL DELIVERY | MAXIM PHARMACEUTICALS, INC. (US) | 2001-02-08 | — | — | WO | disclosed |
| WO-2000040240-A1 | METHODS AND COMPOSITIONS FOR TOPICAL TREATMENT OF DAMAGED TISSUE USING REACTIVE OXYGEN METABOLITE PRODUCTION OR RELEASE INHIBITORS | MAXIM PHARMACEUTICAL, INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| US-6001808-A | ADMINISTERING EFFECTIVE AMOUNT OF GRAMICIDIN FOR THERAPY AND PREVENTION | METATRON, INC. (US) | 1999-12-14 | — | — | US | disclosed |
| US-5861503-A | FLUORINATING WITH FLUORINE OR ACETYL HYPOFLUORITE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-01-19 | — | — | US | disclosed |
| EP-0272446-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1992-11-11 | — | — | EP | disclosed |
| EP-0410660-A1 | Cyclopentane derivatives | GLAXO GROUP LIMITED (GB) | 1991-01-30 | — | — | EP | disclosed |
| EP-0145739-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1989-02-08 | — | — | EP | disclosed |
| EP-0274025-A2 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-07-13 | — | — | EP | disclosed |
| EP-0273169-A2 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-07-06 | — | — | EP | disclosed |
| EP-0272446-A1 | Novel antiviral agents | SRI INTERNATIONAL (US) | 1988-06-29 | — | — | EP | disclosed |
| WO-1984004748-A2 | NOVEL ANTIVIRAL AGENTS | — | 1984-12-06 | — | — | WO | disclosed |